DCAT Value Chain Insights

The EU and Fine Chemicals: Is Change Coming?

The European Commission’s Pharmaceutical Strategy for Europe calls for a structured dialogue to identify vulnerabilities in the pharma supply chain and provide policy options to strengthen medicines...

New Drug Approvals in 2020: Which Drugs Made the Mark?

In 2020, the FDA approved 53 new molecular entities (NMEs), the second highest level of NMEs approved in a given year in the past decade and over the 48 approvals in 2019. What drugs were approved,...

SPONSORED CONTENT

The Role of cGMP Chemicals in Cell & Gene Therapies

Information
December 16, 2020
Sponsored by Avantor

Improvements in raw material inputs are necessary in order to deploy cell & gene therapies economically and at scale. Watch an on-demand webinar featuring Avantor experts to learn about challenges...

Read More
Advancing Gene Therapy by Solving Challenges in Scale-Up & Manufacturing

Information
November 11, 2020
Sponsored by Avantor

Today’s biologic drugs give the promise of breakthrough treatment options for the world’s most challenging diseases and chronic conditions. In the case of gene therapies, the impact of these...

Read More
New Choices to Help Improve mAbs Downstream Manufacturing Efficiency: Introducing the J.T.Baker® BAKERBOND® PROchievA™ Recombinant Protein A Resin

Information
October 7, 2020
Sponsored by Avantor

An integrated mAbs downstream purification process featuring Avantor J.T.Baker® BAKERBOND® PROchievA™ recombinant protein A chromatography columns and resins can enable significant throughput...

Read More